Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Cancer biomarker

Edelweiss: Cancer Open Access journal | cancer biomarker Research articles | Open access Chronic Myeloid Leukemia Articles

A cancer biomarker refers to a substance that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum.

Number of gene and protein based biomarkers have already been used at some point in patient care; including, AFP (Liver Cancer), BCR-ABL (Chronic Myeloid Leukemia), BRCA1 / BRCA2 (Breast/Ovarian Cancer), BRAF V600E (Melanoma/Colorectal Cancer), CA-125 (Ovarian Cancer), CA19.9 (Pancreatic Cancer), CEA (Colorectal Cancer), EGFR (Non-small-cell lung carcinoma), HER-2 (Breast Cancer), KIT (Gastrointestinal stromal tumor), PSA (Prostate Specific Antigen) (Prostate Cancer), S100 (Melanoma).

Edelweiss: Cancer Open Access is an open access journal which aims to publish most complete and genuine source of information in the form of short commentary, mini review, case report, related, but not limited to above areas and making them available freely through online without any subscriptions and restrictions to researches worldwide

Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Cancer biomarker, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.

Related Articles

More Topics in This Journal

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Subscribe for updates

Subscribe

to get latest updates.


  Life Science

  Health Science

  Chemical Science


Subscribe